Drugmaker Says 11th Circ. Ruling Based On 'Straw Man'
By Morgan Conley · November 17, 2021, 7:57 PM EST
The maker of a drug for pediatric patients with a rare autoimmune disease told the Eleventh Circuit it must reconsider a panel ruling in favor of its rival Catalyst Pharmaceuticals Inc....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login